AIM ImmunoTech (AIM) Insider Trading & Ownership $0.09 -0.03 (-22.34%) As of 04/4/2025 This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock AIM ImmunoTech (NYSE:AIM) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.02%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$47,502.14Number OfInsiders Selling(Last 12 Months)0 Get AIM Insider Trade Alerts Want to know when executives and insiders are buying or selling AIM ImmunoTech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address AIM Insider Buying and Selling by Quarter AIM ImmunoTech Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/4/2025Peter W Rodino IIICOOBuy500$0.09$45.00 4/4/2025Thomas K EquelsCEOBuy41,000$0.06$2,460.00 3/4/2025Thomas K EquelsCEOBuy83,334$0.12$10,000.08 12/18/2024Thomas K EquelsCEOBuy22,727$0.21$4,772.67 12/2/2024Stewart AppelrouthDirectorBuy11,112$0.21$2,333.52 11/20/2024Stewart AppelrouthDirectorBuy81,953$0.19$15,571.07 11/20/2024Thomas K EquelsCEOBuy60,110$0.18$10,819.80 9/16/2024Thomas K EquelsCEOBuy5,000$0.30$1,500.00 (Data available from 1/1/2013 forward) AIM Insider Trading Activity - Frequently Asked Questions Who is on AIM ImmunoTech's Insider Roster? The list of insiders at AIM ImmunoTech includes Nancy Bryan, Peter W Rodino III, Stewart Appelrouth, and Thomas K Equels. Learn more on insiders at AIM. What percentage of AIM ImmunoTech stock is owned by insiders? 0.02% of AIM ImmunoTech stock is owned by insiders. Learn more on AIM's insider holdings. Which AIM ImmunoTech insiders have been buying company stock? The following insiders have purchased AIM shares in the last 24 months: Nancy Bryan ($15,000.18), Peter W Rodino III ($25,199.72), Stewart Appelrouth ($47,904.89), and Thomas K Equels ($124,783.67). How much insider buying is happening at AIM ImmunoTech? Insiders have purchased a total of 729,819 AIM shares in the last 24 months for a total of $212,888.46 bought. AIM ImmunoTech Key ExecutivesMr. Thomas K. Equels Esq. (Age 71)J.D., M.S., Executive Vice Chairman, CEO & President Compensation: $953.19k3 recent tradesMr. Robert Dickey IV (Age 68)M.B.A., Chief Financial Officer Compensation: $64.48kMr. Peter W. Rodino III (Age 73)Esq., J.D., COO, Executive Director of Governmental Relations, General Counsel & Secretary Compensation: $484.94k1 recent tradesAnn Marie E. CoverlyDirector of Administration & Human Resources and Deputy Investor Relations CoordinatorDr. Carol A. Smith (Age 73)Chief Manufacturing Officer & Deputy Chief Scientific Officer Compensation: $170.77kDr. Christopher McAleer Ph.D.Scientific OfficerDr. Ralph Christopher Cavalli Ph.D. (Age 66)Vice President of QC & Manufacturing Compensation: $234.79k More Insider Trading Tools from MarketBeat Related Companies SRZN Insider Selling OKUR Insider Selling GBIO Insider Selling CVKD Insider Selling EGRX Insider Selling BCAB Insider Selling TPST Insider Selling CLNN Insider Selling CARA Insider Selling CYTH Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?Sprouts Stock: Insider Sales, But Strong Bullish Signals5 Hot Small-Cap Insiders Bought at the Peak of Tariff FearsThe Top-Ranked Insider Buys From April by Market CapMcDonald’s Insiders Sell Shares! Investors Should Do the Opposite This page (NYSE:AIM) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredHow I profit during chaos…This Guy THRIVES on Chaos Wall Street legend Larry Benedict has thrived through every major market crash. I...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AIM ImmunoTech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AIM ImmunoTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AIM Stock Free AIM Stock Alerts